Document is current
Any future updates will be listed below
-
Authors
Lutomski, Corinne A. https://orcid.org/0000-0001-7509-103X
Bennett, Jack L.
El-Baba, Tarick J. https://orcid.org/0000-0003-4497-9938
Wu, Di https://orcid.org/0000-0001-9748-4408
Hinkle, Joshua D.
Burnap, Sean A.
Liko, Idlir
Mullen, Christopher
Syka, John E. P.
Struwe, Weston B. https://orcid.org/0000-0003-0594-226X
Robinson, Carol V. https://orcid.org/0000-0001-7829-5505
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/V028839/1)
Wellcome Trust (221795/Z/20/Z)
A trans-omic platform to define molecular interactions underlying anhedonia at the blood–brain interface” is supported by Wellcome Leap as part of the Multi-Channel Psych Program.
- License Information
-
More Information
Article History
Received: 8 May 2024
Accepted: 29 November 2024
First Online: 13 January 2025
Competing interests
: J.L.B., D.W., S.A.B. and W.B.S. declare no competing interests. I.L. is an employee of OMass Therapeutics. C.V.R. is a consultant of OMass Therapeutics. J.D.H., C.M. and J.E.P.S. are employees of Thermo Fisher Scientific and are Research and Development Scientists in the life sciences mass spectrometry business. C.A.L., T.J.E., C.V.R., I.L., J.D.H. and J.E.P.S. are inventors on a UK patent application (GB2215982.6) that describes the infrared liberation of membrane proteins from native bilayers for top-down analysis method reported in this paper.
